# Pandemic Influenza Vaccine in Organ Transplantation (PIVOT Trial)

> **NCT07240558** · PHASE3 · RECRUITING · sponsor: **University Health Network, Toronto** · enrollment: 120 (estimated)

## Conditions studied

- Influenza (Pandemic)
- Avian Influenza
- Vaccination

## Interventions

- **BIOLOGICAL:** H5N1 vaccine (Arepanrix, GSK)
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT07240558
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-03
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-12-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07240558

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07240558, "Pandemic Influenza Vaccine in Organ Transplantation (PIVOT Trial)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07240558. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*